Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2004

Open Access 01.12.2004 | Case report

Pseudomyxoma extraperitonei occurring 35 years after appendicectomy: a case report and review of literature

verfasst von: Mamoon H Solkar, Naveed M Akhtar, Zareen Khan, Michael C Parker

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2004

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Pseudomyxoma peritonei is a rare condition consisting of mucinous ascites, most commonly arising from mucinous tumors of the appendix and occasionally from the ovary. Very rarely mucinous implants arise in the retroperitoneum without any intra-peritoneal involvement. This has been termed as pseudomyxoma extraperitonei.

Case presentation

We report a case of a 57 year old man who developed pseudomyxoma extraperitonei, 35 years after undergoing an appendicectomy for a perforated appendix.

Conclusions

Pseudomyxoma extraperitonei has been previously reported, however we report the longest incubation period of 35 years for this condition.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-2-19) contains supplementary material, which is available to authorized users.

Competing interests

None declared.

Background

Pseudomyxoma peritonei is a rare condition consisting of mucinous ascites, most commonly arising from mucinous tumors of the appendix and occasionally from the ovaries. Literally translated it means a false mucinous tumor of the peritoneum. Very rarely mucinous implants arise in the retroperitoneum without any intra-peritoneal involvement. This has been termed as pseudomyxoma extraperitonei. Only 9 cases of pseudomyxoma extraperitonei have been reported in the English literature. [19]
We report a case of pseudomyxoma extraperitonei associated with mucinous adenocarcinoma in a patient who had an appendicectomy performed 35 years previously. This is the longest interval reported between appendicectomy and diagnosis of pseudomyxoma extraperitonei.

Case presentation

A 57 years old Caucasian male was referred to the surgical clinic with vague lower abdominal pain. He had no systemic or bowel symptoms. Abdominal examination revealed a large, fixed mass in the right iliac fossa. The only significant past history was an appendicectomy 35 years ago, in March 1966, when he presented with abdominal pain, fever and vomiting. On examination he was found to have a mass in the right iliac fossa. A diagnosis of an appendicular mass was made and he underwent an interval appendicectomy a few weeks later. At operation a high retro-caecal perforated appendix was seen and the operation to remove the appendix was "difficult" necessitating an extension of the 'grid-iron' incision and insertion of a drain. Postoperatively he developed cellulites and a cutaneous fistula, which subsequently closed. He had remained well and symptom free thereafter until the current presentation. In spite of an extensive search for his past records the histology of the appendix was unavailable.
At present his routine hematological and biochemical tests were within normal limits. A computed tomographic (CT) scan of the chest and abdomen showed a well-defined mass with low attenuation measuring 11 × 6 cm on the right side of the abdomen, extending from the level of the renal hilum to the anterior superior iliac spine. It was closely related to, and distorting, the right psoas muscle. The mass had displaced the ascending colon anteriorly (Figure 1). A CT guided aspiration of the mass yielded mucin and degenerate cellular debris.
At exploratory laparotomy, an encapsulated large mass extending from the right 12th rib to the right lateral pelvic wall was excised intact. It was free from all surrounding structures, including pancreas, kidneys and bowel. The mass was attached to a 2 cm area on the anterior aspect of the quadratus lumborum muscle.
On gross examination the specimen consisted of a partly solid and partly cystic mass measuring 17 × 11 × 6 cm. The cut surface showed myxoid change with areas of necrosis, hemorrhage and calcification. On microscopic examination there was extensive infiltration of the skeletal muscle and fatty tissue by a mucinous adenocarcinoma. Pools of mucin were seen lined by malignant epithelium (Figure 2). There were areas of inflammation; fibrosis, calcification and cholesterol cleft formation.
The patient was treated with adjuvant radiotherapy (40 Gy in 20 fractions) and chemotherapy (weekly injections of 5-fluorouracil and folinic acid given for 30 weeks) making an uneventful recovery. At follow-up three years later there was no sign of recurrence.

Discussion

This unusual case of pseudomyxoma extraperitonei is the tenth reported in the English literature. In this case, a large mucinous adenocarcinoma was attached to a tiny area of the quadratus lumborum muscle, without any involvement of neighboring structures.
Werth [10] in 1884 first described pseudomyxoma peritonei as characterized by the presence of mucinous and gelatinous material in the peritoneal cavity. Earlier hypothesis of the etiology included an inflammatory response with peritoneal metaplasia [11] and active secretions by peritoneal metastases [2, 12, 13]. Some authors use the term pseudomyxoma peritonei only when mucinous ascites is caused by benign peritoneal deposits and metastatic mucinous adenocarcinoma, when malignant cells are identified in the mucinous material [7, 10]. Others however, consider all pseudomyxoma peritonei to be low-grade mucinous adenocarcinoma [1, 10]. More recently, Ronnett et al, [14] have suggested a classification based on tumor pathology where they place all pseudomyxoma peritonei in three groups in order of decreasing prognosis: disseminated peritoneal adenomucinosis (DPAM), peritoneal mucinous carcinoma with intermediate or discordant features (PMCA-I/D) and peritoneal mucinous carcinoma (PMCA) [15].
In 1948 Bonann [3] reported pseudomyxoma involving only the retroperitoneum. This was later termed as pseudomyxoma extraperitonei by Moran [4] in 1988. In eight of the nine case reports of pseudomyxoma extraperitonei the cause was a rupture of an appendiceal mucinous tumor into the retroperitoneum (Table 1). In one, information regarding status of the appendix was not available as the appendicectomy was performed several years previously. An inflammatory response to the mucin leads to fibrosis and encapsulation limiting it to the retroperitoneum.
Table 1
Brief details of previous cases of pseudomyxoma extraperitonei reported in literature
Author
Age / Sex
Clinical Presentation
Treatment
Outcome
Perforated Appendix?
Histology
Brady [1]
67 M
abdominal pain and mass
- debulking of tumor
- further debulking 2 years later with chemotherapy
- additional debulking 3 years later
recurrence after 3 years
yes
mucinous mucocele
Edrees [2]
53 F
abdominal mass
right hemicolectomy & debulking of tumor with chemotherapy
alive and well at 1 year
yes
mucinous adenocarcinoma
Bonann [3]
37 M
tender abdominal mass
evacuation of cyst in 2 stage procedure
not available
yes
mucocoele of appendix
Moran [4]
57 M
tender abdominal mass
- extraperitoneal drainage of cyst
- drained again 3 weeks later with appendicectomy
- further drainage 5 years later with radiotherapy & chemotherapy
alive and well 10 years later
yes
mucocoele of appendix
Mor [5]
65 M
abdominal mass
excision of mass with intraperitoneal spillage of mucus
not available
yes
cyst-adenocarcinoma
Early [6]
57 M
abdominal mass
debulking of tumor
alive and well 2 years later
yes
mucocoele of appendix
Koizumi [7]
46 M
abdominal mass
- right hemicolectomy
- chemotherapy
recurrence of tumor 3 months later
yes
mucinous adenocarcinoma
Matsuoka [8]
58 F
abdominal mass
resection of tumor
not available
possible
mucinous cystadenoma
Shelton [9]
81 M
abdominal mass
removal of all pseudomyxoma deposits and appendicectomy
persistent discharge from wound, survival not available
yes
mucinous cystadenoma
Several treatment modalities with radiotherapy and chemotherapy have been used in treating pseudomyxoma peritonei with varying degrees of success. Recently, Sugarbaker et al, [16] have advocated radical surgery together with perioperative intra-peritoneal and systemic chemotherapy. The reported 5-year survival rate of patients with pseudomyxoma peritonei varies from 11% to 75% (mean 50%) [17]. The role of adjuvant treatment in pseudomyxoma extraperitonei and the survival rates are not known due to the paucity of the reported cases. The prognosis however, is likely to be better than pseudomyxoma peritonei as the vital abdominal structures are not involved [4].
Mucinous implants in the peritoneal cavity are almost always of appendiceal or ovarian origin [6]. Unusual sources of mucinous adenocarcinoma causing pseudomyxoma peritonei have included colon, uterus, common bile duct, pancreas and the stomach [18]. However, a recent report by van Ruth et al, [15] suggests that the appendix is the primary source of most pseudomyxoma peritonei, which may then spread to other sites like the ovaries.
In the absence of any other precipitating cause it seems likely that pseudomyxoma extraperitonei had originated from the perforated appendix in this patient 35 years ago. It appears that a perforation of an appendix containing a mucinous tumor leads to pseudomyxoma and therefore the authors recommend, wherever possible, complete removal of the appendix at appendicectomy and thorough cleansing of the surrounding areas to prevent the occurrence this serious long-term complication.

Conclusions

It is recommended that in an encapsulated pseudomyxoma extraperitonei it is imperative that an intact and complete removal of the mass is achieved without spillage of the mucinous contents in the peritoneum to prevent intraperitoneal extension of the disease.

Author's contributions

MHS collated the information, searched literature and wrote the manuscript.
NA assisted in literature search and writing of the manuscript.
ZK contributed to the pathological aspect of the manuscript.
MCP managed the patient and helped in preparing the manuscript and edited the final version.
All authors have read and approved the final version of the manuscript.

Acknowledgement

Patient consent was obtained for publication of this case report.

Competing interests

None declared.
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Brady MB, Ewing RH, Robinson AE, Dowling EA: Flank mass and pain in a 72 year old man. Invest Radiol. 1986, 21: 419-423.CrossRefPubMed Brady MB, Ewing RH, Robinson AE, Dowling EA: Flank mass and pain in a 72 year old man. Invest Radiol. 1986, 21: 419-423.CrossRefPubMed
2.
Zurück zum Zitat Edrees WK, Hannon RJ: Pseudomyxoma extraperitonei: a rare presentation mimicking an iliacus abscess. The Ulster Med J. 1999, 68: 38-39.PubMed Edrees WK, Hannon RJ: Pseudomyxoma extraperitonei: a rare presentation mimicking an iliacus abscess. The Ulster Med J. 1999, 68: 38-39.PubMed
3.
Zurück zum Zitat Bonnan LJ, Davis JG: Retroperitoneal mucocoele of the appendix. A case report with characteristic roentgen features. Radiology. 1948, 51: 375-382.CrossRef Bonnan LJ, Davis JG: Retroperitoneal mucocoele of the appendix. A case report with characteristic roentgen features. Radiology. 1948, 51: 375-382.CrossRef
5.
Zurück zum Zitat Mor Y, Leibovitch I, Garnick A, Avigad I, Jonas P, Goldwasser B: Pseudomyxoma extraperitonei: an unusual presentation mimicking a huge hydronephrotic kidney. Clin Radiol. 1996, 51: 221-222.CrossRefPubMed Mor Y, Leibovitch I, Garnick A, Avigad I, Jonas P, Goldwasser B: Pseudomyxoma extraperitonei: an unusual presentation mimicking a huge hydronephrotic kidney. Clin Radiol. 1996, 51: 221-222.CrossRefPubMed
6.
Zurück zum Zitat Early KS, Stephenson DV, Davis WC: Giant retroperitoneal mucocoele simulating pseudomyxoma peritonei and mucinous adenocarcinoma. Am J Surg. 1968, 116: 439-443. 10.1016/0002-9610(68)90238-9.CrossRef Early KS, Stephenson DV, Davis WC: Giant retroperitoneal mucocoele simulating pseudomyxoma peritonei and mucinous adenocarcinoma. Am J Surg. 1968, 116: 439-443. 10.1016/0002-9610(68)90238-9.CrossRef
7.
Zurück zum Zitat Koizumi J, Noguchi H: Pseudomyxoma retroperitonei with spontaneous skin fistula. Abdom Imaging. 1999, 24: 193-195. 10.1007/s002619900475.CrossRefPubMed Koizumi J, Noguchi H: Pseudomyxoma retroperitonei with spontaneous skin fistula. Abdom Imaging. 1999, 24: 193-195. 10.1007/s002619900475.CrossRefPubMed
8.
Zurück zum Zitat Matsuoka Y, Masumoto T, Suzuki K, Terada K, Ushimi T, Yokoyama Y, Abe K, Kamata N, Yasuno M, Hishima T: Pseudomyxoma retroperitonei. Eur Radiol. 1999, 9: 457-459. 10.1007/s003300050692.CrossRefPubMed Matsuoka Y, Masumoto T, Suzuki K, Terada K, Ushimi T, Yokoyama Y, Abe K, Kamata N, Yasuno M, Hishima T: Pseudomyxoma retroperitonei. Eur Radiol. 1999, 9: 457-459. 10.1007/s003300050692.CrossRefPubMed
9.
Zurück zum Zitat Shelton MW, Morian JP, Radford DM: Pseudomyxoma retroperitonei associated with appendiceal cystadenoma. Am Surg. 1994, 12: 958-960. Shelton MW, Morian JP, Radford DM: Pseudomyxoma retroperitonei associated with appendiceal cystadenoma. Am Surg. 1994, 12: 958-960.
10.
11.
Zurück zum Zitat Cheng KK: An experimental study of mucocoele of the appendix and pseudomyxoma peritonei. J Pathol Bacteriol. 1949, 61: 217-225.CrossRefPubMed Cheng KK: An experimental study of mucocoele of the appendix and pseudomyxoma peritonei. J Pathol Bacteriol. 1949, 61: 217-225.CrossRefPubMed
14.
Zurück zum Zitat Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH: Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients peritoneal mucinous carcinomatosis. Cancer. 2001, 92: 85-91. 10.1002/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R.CrossRefPubMed Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH: Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients peritoneal mucinous carcinomatosis. Cancer. 2001, 92: 85-91. 10.1002/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R.CrossRefPubMed
15.
Zurück zum Zitat Van Ruth S, Acherman YIZ, van de Vijwer MJ, Hart AA, Verwaal VJ, Zoetmulder FA: Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol. 2003, 29: 682-688. 10.1016/S0748-7983(03)00149-5.CrossRefPubMed Van Ruth S, Acherman YIZ, van de Vijwer MJ, Hart AA, Verwaal VJ, Zoetmulder FA: Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol. 2003, 29: 682-688. 10.1016/S0748-7983(03)00149-5.CrossRefPubMed
16.
Zurück zum Zitat Sugarbaker PH, Kern K, Lack E: Malignant pseudomyxoma peritonei of colonic origin: natural history and presentation of a curative approach to treatment. Dis Colon Rectum. 1987, 30: 772-779.CrossRefPubMed Sugarbaker PH, Kern K, Lack E: Malignant pseudomyxoma peritonei of colonic origin: natural history and presentation of a curative approach to treatment. Dis Colon Rectum. 1987, 30: 772-779.CrossRefPubMed
17.
Zurück zum Zitat Sherer D, Abulafia O, Eliakim R: Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest. 2001, 51: 73-80. 10.1159/000052897.CrossRefPubMed Sherer D, Abulafia O, Eliakim R: Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest. 2001, 51: 73-80. 10.1159/000052897.CrossRefPubMed
18.
Zurück zum Zitat Higa E, Rosai J, Pizzimbono CA, Wise L: Mucosal hyperplasia, mucinous cystadenoma and mucinous cystadenocarcinoma of the appendix. a re-evaluation of appendiceal 'mucocoele'. Cancer. 1973, 33: 1525-1541.CrossRef Higa E, Rosai J, Pizzimbono CA, Wise L: Mucosal hyperplasia, mucinous cystadenoma and mucinous cystadenocarcinoma of the appendix. a re-evaluation of appendiceal 'mucocoele'. Cancer. 1973, 33: 1525-1541.CrossRef
Metadaten
Titel
Pseudomyxoma extraperitonei occurring 35 years after appendicectomy: a case report and review of literature
verfasst von
Mamoon H Solkar
Naveed M Akhtar
Zareen Khan
Michael C Parker
Publikationsdatum
01.12.2004
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2004
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-2-19

Weitere Artikel der Ausgabe 1/2004

World Journal of Surgical Oncology 1/2004 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.